Evidence map›Paper›PMID 35260716›Full record

ArticleScientific reports2022

Structural and immunoendocrine remodeling in gut, pancreas and thymus in weaning rats fed powdered milk diets rich in Maillard reactants.

J Dereke, E Ekblad, B Weström, C Erlanson-Albertsson, M Landin-Olsson, I Sjöholm, M Hillman

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J DerekeDepartment of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
E EkbladNeurogastroenterology Unit, Department of Experimental Medical Science, Faculty of Medicine, Lund University, BMC, B11, Sölvegatan 19, 22184, Lund, Sweden. eva.ekblad@med.lu.se.
B WeströmDepartment of Biology, Faculty of Science, Lund University, Lund, Sweden.
C Erlanson-AlbertssonNeurogastroenterology Unit, Department of Experimental Medical Science, Faculty of Medicine, Lund University, BMC, B11, Sölvegatan 19, 22184, Lund, Sweden.
M Landin-OlssonDepartment of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
I SjöholmDepartment of Food Technology, Engineering and Nutrition, Faculty of Engineering, Lund University, Lund, Sweden.
M HillmanDepartment of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Western diet is extending worldwide and suspected to be associated with various metabolic diseases. Many food products have skim milk powder added to it and, during processing, lactose reacts with milk proteins and Maillard reaction products (MRPs) are formed. Dietary MRPs are suggested risk factors for metabolic dysregulation, but the mechanisms behind are still enigmatic. Here we describe that weaning rats fed diets rich in MRPs are affected in both their immune and endocrine systems. Marked structural changes in pancreas, intestine and thymus are noted already after 1 week of exposure. The pancreatic islets become sparser, the intestinal mucosa is thinner, and thymus displays increased apoptosis and atrophy. Glucagon- like peptide-1 (GLP-1) seems to play a key role in that the number of GLP-1 expressing cells is up-regulated in endocrine pancreas but down-regulated in the intestinal mucosa. Further, intestinal GLP-1-immunoreactive cells are juxta positioned not only to nerve fibres and tuft cells, as previously described, but also to intraepithelial CD3 positive T cells, rendering them a strategic location in metabolic regulation. Our results suggest dietary MRPs to cause metabolic disorders, dysregulation of intestinal GLP-1- immunoreactive cells, arrest in pancreas development and thymus atrophy.

Indexed as

Metabolic DiseasesPancreasAnimalsAtrophyDietGlucagon-Like Peptide 1Glycation End Products, AdvancedPowdersRatsWeaningGlucagon-Like Peptide 1Glycation End Products, AdvancedPowders

Identifiers

PMID35260716
PMCPMC8904556
OpenAlexW4220667301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.